Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12071465 Methods of making and using extracellular domain-based chimeric proteins

Patent 12071465 was granted and assigned to Shattuck Labs on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Suresh De Silva0

Taylor Schreiber0

George Fromm0

Date of Patent

August 27, 2024

0

Patent Application Number

177177400

Date Filed

April 11, 2022

0

Patent Citations

US Patent 8450460 Single-chain TNFSF fusion polypeptides

0

US Patent 8735553 Anti-PD1 antibodies and their use as therapeutics and diagnostics

0

US Patent 8921519 Single chain fusion polypeptides comprising soluble light cytokine domains

0

US Patent 9029315 Soluble PD-1 variants, fusion constructs, and uses thereof

0

US Patent 9061073 Antibody-light fusion products for cancer therapeutics

0

US Patent 9221895 OX40/TRAIL fusion proteins

0

US Patent 9352037 Compositions and methods to enhance the immune system

0

US Patent 9388230 Compositions and methods for treatment of hematological malignancies

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

Patent abstract

The present invention relates, inter alia, to compositions and methods, including chimeric proteins and combination therapies that find use in the treatment of disease, such as cancer and/or an inflammatory disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12071465 Methods of making and using extracellular domain-based chimeric proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool